| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/08/2004 | EP1453816A2 Phenoxy amine compounds and compositions for delivering active agents |
| 09/08/2004 | EP1453781A2 Method for the production of $g(a) mannite directly compressible into tablets |
| 09/08/2004 | EP1453598A1 Method for preparing a multiple water/oil/water emulsion |
| 09/08/2004 | EP1453557A2 Improved stent coating |
| 09/08/2004 | EP1453556A1 Method for forming matrices of hardened material |
| 09/08/2004 | EP1453546A2 Treatment of angiogenesis disorders using targeted nanoparticles |
| 09/08/2004 | EP1453545A1 Water-soluble polymer conjugates of retinoic acid |
| 09/08/2004 | EP1453544A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 09/08/2004 | EP1453542A1 Nutraceutical composition |
| 09/08/2004 | EP1453526A2 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
| 09/08/2004 | EP1453525A1 Selective targeting of apoptotic cells |
| 09/08/2004 | EP1453523A1 Heparin-containing ophthalmic agent |
| 09/08/2004 | EP1453517A1 Platinum derivative pharmaceutical formulations |
| 09/08/2004 | EP1453508A1 Tempamine compositions and use against cellular oxidative damage |
| 09/08/2004 | EP1453502A2 Pharmaceutical formulations comprising indolinone derivatives |
| 09/08/2004 | EP1453491A1 Transdermal delivery devices |
| 09/08/2004 | EP1453490A1 Process for making pre-formed objects |
| 09/08/2004 | EP1453489A2 Acetaminophen compositions |
| 09/08/2004 | EP1453488A1 Improved edible film formulations containing maltodextrin |
| 09/08/2004 | EP1453487A1 Pharmaceutical dosage form with multiple coatings |
| 09/08/2004 | EP1453486A2 Dual stage microvalve and method of use |
| 09/08/2004 | EP1453485A2 Matrices for stabilizing and controlled release of problematic substances |
| 09/08/2004 | EP1453484A2 Methods and materials for detecting genetic material |
| 09/08/2004 | EP1453483A2 High-concentration lidocaine compositions and methods for their preparation |
| 09/08/2004 | EP1453482A1 Radioopaque sustained release pharmaceutical system |
| 09/08/2004 | EP1453481A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 09/08/2004 | EP1453447A1 Composition and transdermal drug delivery device |
| 09/08/2004 | EP1383512B1 Use of sucralfate for the treatment of cervical erosion |
| 09/08/2004 | EP1379261A4 Method for increasing serotonin levels in a person by administration of a composition incorporating (-)-hydroxycitric acid, and related compositions thereof |
| 09/08/2004 | EP1347744B1 Solid dispersions of nitrate active principles |
| 09/08/2004 | EP1326624B1 Method for producing phyllanthus extracts |
| 09/08/2004 | EP1292281B1 Novel tiotropium-containing inhalation powder |
| 09/08/2004 | EP1235571B1 Use of melatonin for treating androgenetic and diffuse female type alopecia |
| 09/08/2004 | EP1233760B1 Orally administrable pharmaceutical product and method of fabrication thereof |
| 09/08/2004 | EP1225897B1 Composition for treatment of constipation and irritable bowel syndrome |
| 09/08/2004 | EP1189579B1 Gelled aqueous cosmetic compositions |
| 09/08/2004 | EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes |
| 09/08/2004 | EP1172097B1 Process for producing medicinal composition of a basic hydrophobic medicinal compound |
| 09/08/2004 | EP1079839B1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 09/08/2004 | EP1014954B9 Transdermal therapeutic system |
| 09/08/2004 | EP0977780B1 Hetero-polysaccharide conjugates, s-inp polysaccharide gels and methods of making and using the same |
| 09/08/2004 | EP0893989B1 Compounds combining allopathic substances with corresponding homeopathic substances |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | EP0723437B1 Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 09/08/2004 | CN1527839A Modified human brain-derived neutrophic factor (BDNF) with reduced immunogenicity |
| 09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 09/08/2004 | CN1527729A Topical pharmaceutical formulation |
| 09/08/2004 | CN1527724A Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/08/2004 | CN1527719A Tryptophanyl-tRNA synthetase derived polypeptides useful for the regulation of angiongenesis |
| 09/08/2004 | CN1527718A Method for short-term and long-term drug dosimetry |
| 09/08/2004 | CN1527714A Pharmaceutical composition and method for treating hypogonadism |
| 09/08/2004 | CN1527713A Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 09/08/2004 | CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency |
| 09/08/2004 | CN1527706A Pharmaceutical compositions containing terbinafin and use thereof |
| 09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
| 09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 09/08/2004 | CN1527702A Nutritional supplements and methods of using same |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1527700A Compaction process for manufacture of sodium phenytoin dosage form |
| 09/08/2004 | CN1527699A Stable injecta composition and method |
| 09/08/2004 | CN1527698A 控释可生物降解的凝胶基质 Controlled release biodegradable gel matrix |
| 09/08/2004 | CN1527697A Immune modulation device for use in animals |
| 09/08/2004 | CN1527689A Insert for the treatment of dry eye |
| 09/08/2004 | CN1527670A Aimal growth regulating composition and its prepn and use |
| 09/08/2004 | CN1526730A Erythrocytosis factor and its production process |
| 09/08/2004 | CN1526449A Method of eliminating and inhibiting bitter of medicine |
| 09/08/2004 | CN1526448A Medicine and method for the treatment of anorectal disorders |
| 09/08/2004 | CN1526441A Agastache capsule for restoring healthy energy andits prepn and application |
| 09/08/2004 | CN1526440A Compound Chinese medicine prepn for treating muscular atrophy and amyasthenia and its prepn process |
| 09/08/2004 | CN1526439A Chinese medicine for treating women's sterility and its prepn and use |
| 09/08/2004 | CN1526438A Chinese medicine for treating tuberculosis and its prepn and use |
| 09/08/2004 | CN1526433A Compound American ginseng prepn and its prepn process |
| 09/08/2004 | CN1526432A Medicine for treating piles |
| 09/08/2004 | CN1526431A Chinese medicine for treating osteological diseases and its prepn process |
| 09/08/2004 | CN1526427A Antiviral Chinese medicine prepn of Hypericum perforatumand its prepn process |
| 09/08/2004 | CN1526426A Inflammation diminishing and granulation promoting medicine powder |
| 09/08/2004 | CN1526424A Swelling eliminating and pain relieving plaster |
| 09/08/2004 | CN1526421A Prepn of single ingredient granule |
| 09/08/2004 | CN1526413A Dry rhizopus bacteria suspension and its prepn process and use |
| 09/08/2004 | CN1526412A Making process of nanometer level pearl powder and shell powder |
| 09/08/2004 | CN1526408A Ribavirin gel as eye medicine and its production process |
| 09/08/2004 | CN1526407A Antitumor protopanoxadiol injection and its prepn process |
| 09/08/2004 | CN1526406A Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
| 09/08/2004 | CN1526405A Antitumor ginsenoside Rg3 injection and its prepn process |
| 09/08/2004 | CN1526404A Antitumor ginsenoside C-K injection and its prepn process |
| 09/08/2004 | CN1526403A Antitumor ginsenoside Rh2 injection and its prepn process |
| 09/08/2004 | CN1526399A Diammonium glycyrrhizinate freeze drying powder for injection and its prepn |
| 09/08/2004 | CN1526398A Compound blood pressure reducing prepn containing angiotonin converzyme inhibitor, calcium ion agonist and Estazolam |
| 09/08/2004 | CN1526397A Combined antibiotic medicine for inhibiting beta-lactamase |
| 09/08/2004 | CN1526395A Tegafur-sodium chloride injection and its prepn |
| 09/08/2004 | CN1526394A Buspirone hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526393A Hydralazine hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526392A Cetirizine hydrochloride guttate pills and the prepn |
| 09/08/2004 | CN1526390A Piduomode granule and its prepn |
| 09/08/2004 | CN1526387A Taxol vesicle injection and its prepn |
| 09/08/2004 | CN1526386A Houttuynin sodium powder injection and its prepn |
| 09/08/2004 | CN1526385A Ditropan hydrochloride dripping pills and the prepn process |
| 09/08/2004 | CN1526384A Quickly disintegrated fenofibrate oral prepn |
| 09/08/2004 | CN1526383A Jiafuming and Glibenclamide solid oral preparation and preparing method thereof |
| 09/08/2004 | CN1526382A Sertraline hydrochloride dripping pills and the prepn |